MLchartDataset catalogue

VAdriaC regimen

Term · Oncology and biomedicine · MLC-T-ONC-009135

An abbreviation for a chemotherapy combination used to treat Ewing sarcoma and other sarcomas, such as mesenchymal chondrosarcoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and cyclophosphamide. Also called VAdriaC.

Table 1. Record
IdentifierMLC-T-ONC-009135
FieldOncology and biomedicine
SynonymsVAdriaC
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-009135",
  "term": "VAdriaC regimen",
  "field": "Oncology and biomedicine",
  "definition": "An abbreviation for a chemotherapy combination used to treat Ewing sarcoma and other sarcomas, such as mesenchymal chondrosarcoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and cyclophosphamide. Also called VAdriaC.",
  "synonyms": [
    "VAdriaC"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/vadriac-regimen/"
}

Record 17,066 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.